Wells Fargo & Company »

Outlook Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Outlook Therapeutics shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $16k 41k 0.40
2023-09-30 $6.8k 31k 0.22
2023-06-30 $352k 203k 1.73
2022-12-31 $150k 139k 1.08
2022-09-30 $201k 141k 1.43
2022-06-30 $116k 128k 0.91
2022-03-31 $174k 97k 1.79
2021-12-31 $107k 78k 1.37
2021-09-30 $15k 7.0k 2.13
2021-06-30 $0 31 0.00
2021-03-31 $1.1k 616 1.71
2020-12-31 $0 394 0.00
2020-09-30 $0 343 0.00
2020-06-30 $0 211 0.00
2020-03-31 $0 141 0.00